Optimising bone health in survivors of breast cancer.
Bundred
Nigel J
NJ
D000730:Androstadienes / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D015415:Biomarkers / Q000378:metabolism*; D015519:Bone Density / Q000187:drug effects*; D001859:Bone Neoplasms / Q000188:drug therapy / Q000556:secondary; D016723:Bone Remodeling / Q000187:drug effects*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology; D005260:Female; D006801:Humans; D017698:Postmenopause; D017741:Survivors; D013629:Tamoxifen / Q000008:administration & dosage
D000730:Androstadienes; D015415:Biomarkers; D013629:Tamoxifen; C056516:exemestane